Bengaluru-headquartered biopharma company PlasmaGen Biosciences has raised Rs 225 crore from UK-based Artian Investments, public markets investor Ashish Kacholia, pharma industry entrepreneurs ...
"Interested in increasing supplies of Indian products in Russia," says Russian Minister Maxim Reshetnikov ...
Plasmagen Biosciences specializing exclusively in plasma protein and speciality care therapy, has recently announced the launch of Haemocomplettan P (Human Fibrinogen Concenrate), manufactured by CSL ...
Eight Roads Ventures-backed biopharmaceutical firm Plasmagen Biosciences has named a former Abbott India senior executive as the chief executive to drive international expansion of its plasma ...
New Delhi: Plasmagen Biosciences Private Ltd., specialising in Plasma Protein and Speciality Care Therapy, has announced the introduction of Haemocomplettan P (Human Fibrinogen Concenrate), ...
Biopharmaceutical company PlasmaGen BioSciences Pvt. Ltd said on Tuesday it has raised $25 million (Rs 160.4 crore) from investors led by private equity firm Eight Roads Ventures India. US-based ...
On Tuesday, Bengaluru-based biopharmaceutical company PlasmaGen BioSciences Private Limited announced having raised an investment of close to $25 million in a round led by Eight Roads Ventures India ...
Biopharmaceutical company PlasmaGen BioSciences has raised $25 million funding led by Eight Roads Ventures with participation from US-based F-Prime Capital Partners and the founders. PlasmaGen was ...
Bengaluru (Karnataka) [India], May 30: PlasmaGen Biosciences ('PlasmaGen'), a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, recently ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results